Medical Cannabis Dose Patterns and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest modest THC dosing may relate to anxiety, insomnia, and multi-symptom improvement in pancreatic cancer, while also exposing major feasibility challenges in advanced cancer research. It keeps the…
What CANPAN Suggests About THC Dose and Symptoms in Pancreatic Cancer
medical cannabis research: A small CANPAN analysis links higher daily THC exposure with better anxiety and insomnia scores in pancreatic cancer, while also exposing major feasibility and missing-data challenges for future trials. It keeps the evidence…
Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…
Nose to Brain CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the concept remains preclinical and unproven in children. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but human pediatric safety, dosing, and efficacy data remain absent. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox-Gastaut Syndromes, Promise Before Proof
medical cannabis research: A 2026 review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the clinical evidence remains preclinical and translational. It keeps the evidence readable for…
Cannabis Science and Research Digest: Nanostructured lipid carriers for intranasal…
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The takeaway is educational rather than…
Cannabis Science and Research Digest: Comparative Efficacy and Safety of Tirzepati…
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The takeaway is educational rather than…
Cannabis Use in Adolescents: Understanding Endocannabinoid System’s Role
Clinical Takeaway Adolescents with higher levels of depression, generalized anxiety, social anxiety, and panic are more likely to use cannabis over time as a coping mechanism. This study confirms an internalizing pathway linking these mental health…
Nonintoxicating Cannabinoids Eased Arthritis Pain in This Study. There Was No Placebo Group.
A 2026 study in Clinical Therapeutics reported that three oral cannabinoid formulations improved pain and related symptoms in fibromyalgia, rheumatoid arthritis, and osteoarthritis over twelve weeks, with no placebo group. Every placebo-controlled trial…
